EUFOREA Comment on Misleading Allergic Rhinitis Report
In this article, members of the EUFOREA Allergic Rhinitis Expert Panel provide a critical analysis of the study titled "Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study," published in Patient Preference and Adherence.
Guided by the premise of seeking new evidence of efficacy and acceptability of rhinitis treatments, reflecting EUFOREA's ambition to optimise the therapy of chronic respiratory diseases, we have discussed its concept, conduct and conclusions.
The authors of this paper are Prof. Glenis Scadding (UK), Prof. Peter Hellings (Belgium) and Prof. Pete Smith (Australia).